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Interleukin 10 (IL-10) is an important anti-inflammatory cytokine. To examine its role in virus-induced encephalomyelitis,
IL-10-deficient (IL-10 2/2) mice were infected with a neurotropic strain of mouse hepatitis virus (JHMV). JHMV-infected IL-10
2/2 mice, compared to IL-4 2/2 and syngeneic C57BL/6 mice, exhibited increased morbidity and mortality. Virus was
cleared from the CNS of all groups of mice with equal kinetics by day 9 postinfection and the lack of either IL-4 or IL-10 did
not alter the distribution of viral antigen, suggesting a lack of correlation between viral replication and the increased clinical
disease in IL-10 2/2 mice. In moribund IL-10 2/2 mice, a moderate increase in mononuclear cell infiltration was correlated
with increased expression of tumor necrosis factor-a, interferon-g, and inducible nitric oxide synthase mRNAs. In the small
percentage of IL-10 2/2 mice that survived, no differences in either demyelination or inflammation were observed. Together,
these results suggest that IL-10 is not required for viral clearance, and although it appears to be one of the mechanisms
responsible for inhibiting the extent of inflammation in the CNS during acute JHMV infection, it has little role in the eventual
resolution of CNS inflammatory responses. © 1998 Academic Press
INTRODUCTION
Immunity to viral infections of the central nervous
system (CNS) must attempt to balance the limitation of
viral replication and its cytopathology with the preserva-
tion of CNS function. Infection of the CNS by the neuro-
tropic JHM strain of mouse hepatitis virus (JHMV) pro-
vides one example of these complex responses. JHMV
infection produces an acute panencephalomyelitis
which progresses to persistent infection accompanied
by chronic ongoing demyelination (Weiner, 1973). Elimi-
nation of infectious virus is important for protection from
lethal encephalitis; however, protection and viral clear-
ance may be distinct immunological events (Kyuwa and
Stohlman, 1990; Houtman and Fleming, 1996; Lane and
Buchmeier, 1997). Some immune effectors, such as cy-
totoxic T lymphocytes (CTL), prevent death via directly
reducing CNS viral replication (Stohlman et al., 1995a;
Lin et al., 1997), while other components, for instance
virus-specific CD41 T cells, may protect without altering
viral replication (Stohlman et al., 1986; Korner et al., 1991;
Yamaguchi et al., 1991). Elimination of detectable infec-
tious virus, without complete elimination of viral antigen
or viral RNA (Perlman and Ries, 1987; Adami et al., 1995),
suggests a moderated anti-viral immune response de-
signed to preserve CNS function at the expense of viral
elimination, thereby contributing to persistent infection.
Analysis of cytokine mRNA within the CNS during JHMV
infection showed that both IL-10 and IL-4 mRNA accu-
mulate with kinetics similar to the mRNA encoding the
proinflammatory cytokines, interferon-g (IFN-g) and tu-
mor necrosis factor-a (TNF-a) (Parra et al., 1997). While
the induction of IL-10, TNF-a, and IFN-g mRNA levels
were similar, induction of IL-4 mRNA was considerably
lower (Parra et al., 1997), suggesting that few T cells
secreting Th2-type cytokines are recruited into the CNS
during JHMV infection.
Several mechanisms for modulation of immune re-
sponses within the CNS have been proposed. For exam-
ple, lipids within the local CNS environment have been
suggested to limit viral-induced inflammation by inhibit-
ing IL-2 production from infiltrating lymphocytes (Irani et
al., 1997). Th2-derived cytokines, including IL-10, are im-
portant in prevention of experimental allergic encepha-
lomyelitis (EAE) (Rott et al., 1994) and correlate with
disease remission (Kennedy et al., 1992; Issazadeh et al.,
1996). IL-10 suppresses macrophage functions as well
as Th1-type T cell responses (Moore et al., 1993). IL-4
protects from neuronal injury via inhibition of TNF-a and
nitric oxide (NO) production by activated microglia (Chao
et al., 1993). By contrast, the expression of TNF-a is
associated with progression of EAE (Navikas and Link,
1996). Microglia express TNF-a during JHMV-induced
encephalomyelitis (Stohlman et al., 1995b; Sun et al.,
1995); however, TNF-a appears to play no direct role in
the progression of disease (Stohlman et al., 1995b).
These data suggested that at least with respect to TNF-a,
JHMV-induced inflammation is distinct from the inflam-
1 To whom reprint requests should be addressed at University of
Southern California School of Medicine, MCH 142, 1333 San Pablo St.,
Los Angeles, CA 90033. Fax: 213-225-2369.
VIROLOGY 245, 270–280 (1998)
ARTICLE NO. VY989170
0042-6822/98 $25.00
Copyright © 1998 by Academic Press
All rights of reproduction in any form reserved.
270
mation associated with CNS autoimmune disease. In
this report, the potential role of IL-10 to modify viral-
induced encephalomyelitis was examined by infection of
mice rendered genetically deficient in IL-10 via homolo-
gous gene recombination.
RESULTS
To examine the potential role(s) of IL-10 in JHMV in-
fection, clinical disease progression and mortality in
IL-10 2/2 mice were compared to those of IL-4 2/2
mice and syngeneic C57BL/6 mice. All groups of mice
developed mild encephalitis (ruffled fur, hunched back,
minor gait abnormality) between days 7 and 8 p.i., pro-
gressed to moderate paraparesis by day 13, and showed
signs of recovery by day 18 p.i. (Fig. 1A). IL-10 2/2 mice
exhibited a transient, yet significant, increase (P value ,
0.05) in disease, compared to either the IL-4 2/2 or
C57BL/6 control mice, between days 8 and 10 p.i. (Fig.
1A). At the peak of clinical disease (day 11 p.i.), differ-
ences were no longer statistically significant, although
the IL-10 2/2 group exhibited higher average clinical
grades than the other groups throughout the remainder
of the experiment (Fig. 1A). A reduced survival rate was
found in the IL-10 2/2 group (Fig. 1B), consistent with
the increased clinical scores. Approximately one-third of
mice in both the IL-4 2/2 and C57BL/6 groups suc-
cumbed to JHMV infection (Fig. 1B). By contrast, a much
higher proportion (P value , 0.005) of IL-10 2/2 mice
died between days 9 and 14 p.i. (Fig. 1B). Mean day of
survival for the IL-10 2/2 group was 12.8 days compared
to the IL-4 2/2 (19.1 days) and the control group (18.6
days). These data suggest that IL-10, but not IL-4, is
important for survival during JHM-induced encephalomy-
elitis, consistent with the low level of IL-4 and higher
level of IL-10 mRNA associated with JHMV infection
(Parra et al., 1997).
IL-10 is associated with decreasing CNS inflammation
(Rott et al., 1994; Navikas and Link, 1996) and autoim-
mune CNS disease remission (Kennedy et al., 1992;
Issazadeh et al., 1996) and is an important anti-inflam-
matory cytokine limiting immune responses during a
variety of systemic infections (Kuhn et al., 1993; Moore et
al., 1993; Gallo et al., 1994; Tonnetti et al., 1995; Gazzinelli
et al., 1996; Dai et al., 1997; Hunter et al., 1997). To
determine whether the increased morbidity and mortality
observed in JHMV-infected IL-10 2/2 mice correlated
with increased or prolonged mononuclear cell infiltration,
histopathological changes in the CNS of IL-10 2/2, IL-4
2/2, and C57BL/6 mice were compared. At day 7 p.i., all
groups had similar numbers and distribution of inflam-
matory foci, consistent with the absence of a difference
in clinical disease at this time point (data not shown).
Only a moderate increase in CNS inflammation was
observed in the IL-10 2/2 mice when compared to the
control groups at day 9 p.i. (Figs. 2A and 2B), consistent
with the transient increase in clinical scores observed
(Fig. 1A). By day 18 p.i., the surviving IL-10 2/2 mice had
similar numbers of spinal cord demyelination plaques
(IL-10 2/2 mice, 6.1 6 1.9, and control mice, 7.6 6 1.3)
and cellular infiltrates when compared to control mice
(Figs. 2C and 2D), suggesting that IL-10 does not influ-
ence the development of JHMV-induced demyelination.
Furthermore, no infectious virus was recovered from
these survivors, although viral antigen, indicative of per-
sistent infection, was still present (data not shown).
These data suggest that even in the absence of IL-10, the
immune response remains unable to completely elimi-
nate virus from the CNS.
JHMV clearance from the CNS is predominantly de-
pendent on T cell immunity (Kyuwa and Stohlman, 1990;
Stohlman et al., 1995a; Lane and Buchmeier, 1997). Both
IL-10 and IL-4 are important T cell growth and maturation
factors (Widmer and Grabstein, 1987; Chen and Zlotnik,
1991), in addition to their potential anti-inflammatory
roles (Moore et al., 1993; Powrie et al., 1993; Brown and
Hural, 1997). Therefore, JHMV replication in the CNS of
IL-10 2/2, IL-4 2/2, and C57BL/6 mice was compared
to test the possibility that the increased clinical scores
observed in IL-10 2/2 mice reflected an inability to
eliminate infectious virus. A small but significant in-
FIG. 1. Morbidity and mortality of IL-10 2/2, IL-4 2/2, and C57BL/6
mice undergoing JHMV infection. (A) Groups of 16 to 20 IL-10 2/2, IL-4
2/2, and C57BL/6 were infected ic with 25 PFU JHMV and observed
for clinical scores as described under Materials and Methods. (*)
Denotes statistical significance (P , 0.05, Kruskal–Wallis test). (B)
Survival rates of JHMV-infected IL-10 2/2, IL-4 2/2, and C57BL/6 mice
(P , 0.005, Mantel–Cox test).
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FIG. 2. Histology of CNS in JHMV-infected IL-10 2/2 and C57BL/6 mice. In (A), a brain section from an IL-10 2/2 mouse at day 9 p.i. shows
multifocal cellular infiltrates (arrows). In (B), a section from a similarly infected C57BL/6 mice shows less prominent inflammation (arrows). At 18 days
p.i., spinal cords of both IL-10 2/2 (C) and C57BL/6 (D) mice show demyelination (arrows) and mild chronic inflammation. Hematoxylin and eosin
stain. Magnification, 3110.
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crease in infectious virus was detected in both the IL-10
2/2 and IL-4 2/2 mice compared to C57BL/6 mice at
day 7 p.i. (Fig. 3A). However, infectious virus was cleared
from the CNS of all groups by day 9 p.i. (Fig. 3A). To
confirm the transient increase in virus detected at day
7 p.i. and complete virus clearance by day 9 p.i., repli-
cation was also examined in infected C57BL/6 mice
deleted of IL-4 or IL-10 via antibody treatment. Antibody-
FIG. 2—Continued
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mediated IL-4 and IL-10 depletions also resulted in a
transient increase in virus replication at day 7 p.i.
(Fig.3B). Similarly, no infectious virus was detected in
either antibody-treated group at day 9 p.i.. These data
confirm that both IL-4 and IL-10 contribute to the early
clearance of virus from the CNS; however, neither are
necessary for complete elimination of infectious virus. In
addition, although more CD41 and CD81 T cells were
present in the CNS of the IL-10 2/2 mice compared to
control mice at day 9 p.i. (data not shown), the ratio of
CD41 to CD81 lymphocytes remained at 2:1 in both
groups, suggesting that IL-10 does not participate in the
differential regulation of T cell trafficking into the CNS.
Infectious virus could not be detected at the time when
most of the IL-10 2/2 mice succumb to infection (day
9-14 p.i., Fig. 1B). These data suggest that the increased
morbidity and mortality observed in IL-10 2/2 mice was
not due to changes in JHMV replication.
Distribution of viral antigen was examined to deter-
mine if the tropism of JHMV was altered during infection
of the IL-10 2/2 mice and had thus contributed to the
increased morbidity and mortality. No difference in the
numbers of antigen-positive cells was observed compar-
ing all groups at day 7 p.i. (data not shown); however,
increased numbers of antigen-positive cells were ob-
served in the IL-10 2/2 mice at day 9 p.i. (Figs. 4A and
4B) when infectious virus was no longer detectable.
Importantly, at no point during the infection was a differ-
ence in JHMV-infected cell types noted, suggesting that
the absence of IL-10 did not contribute to clinical disease
by altering CNS cellular tropism. Although IL-10 2/2
mice succumb to chronic enterocolitis (Kuhn et al., 1993),
no evidence of inflammatory disease or secondary infec-
tion was detected in colon, kidney, and liver from ran-
domly selected moribund IL-10 2/2 mice (data not
shown). Systemic infections of IL-10 2/2 mice are also
associated with increased TNF-a expression correlating
with tissue destruction and morbidity (Gazzinelli et al.,
1996; Dai et al., 1997). To determine if increased TNF-a
expression correlated with the morbidity and mortality of
the JHMV-infected IL-10 2/2 mice, TNF-a mRNA expres-
sion within the CNS and serum levels of TNF-a were
examined. In the CNS of moribund IL-10 2/2 mice at day
9 p.i., a threefold increase in TNF-a mRNA level was
detected over that of the control mice (Fig. 5); however,
no serum TNF-a was detected (, 2.5 units/ml) (data not
shown), confirming the absence of a systemic inflamma-
tory process. In addition to CNS TNF-a mRNA expres-
sion, the levels of IFN-g and iNOS, both indicators of
inflammatory responses, and TGF-b mRNA, an anti-in-
flammatory cytokine, were also examined (Fig. 5). The
amount of CNS IFN-g and iNOS mRNA expression was
also increased three- to fourfold in moribund IL-10 2/2
mice. By contrast, the amount of TGF-b mRNA was not
different between the two groups. The amounts of TNF-a,
iNOS, IFN-g, and TGF-b mRNA expression in the
C57BL/6, IL-4 2/2, and nonmoribund IL-10 2/2 mice
were similar (data not shown), indicating that increased
viral burden did not contribute to the increased expres-
sion of proinflammatory cytokines in the IL-10 2/2 mice.
These data suggest that increased expression of inflam-
matory cytokines due to a lack of IL-10 regulation could
contribute to the increased morbidity and mortality in the
IL-10 2/2 mice.
DISCUSSION
Infection of the CNS by JHMV results in a vigorous
immune infiltrate, composed of natural killer cells, CD41
T cells, and CD81 T cells (Dorries et al., 1991; Williamson
FIG. 3. JHMV titer in the brain of JHMV-infected mice. (A) Virus titers
in IL-10 2/2, IL-4 2/2, and control mice and (B) anti-cytokine mAb-
treated mice at days 7 and 9 p.i. To deplete IL-4 and IL-10, C57BL/6
mice were injected intraperitoneally with 1 mg of anti-IL-4 (11B11) or
anti-IL-10 (JES5-2A5) mAbs at 2 days prior to and 2 days post JHMV
infection. Virus titers were determined by plaque assay as described
under Materials and Methods. Each time point represents the mean of
four samples and the standard errors are expressed as error bars.
Student’s t test was used to test for significance. (*) Denotes P , 0.05
and (–) denotes titers below detection level (,200 PFU).
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FIG. 4. JHMV antigen in the CNS of IL-10 2/2 and C57BL/6 mice. In (A), a brain section from an IL-10 2/2 mouse at day 9 p.i. shows increased
numbers of antigen-positive cells (arrows) compared to similarly infected C57BL/6 mice (B). In each group, a mixed population of glial cells and small
numbers of neurons are stained. Immunoperoxidase stain using the ABC method for viral antigen in conjunction with anti-JHMV mAb J.3.3 and
counterstained with hematoxylin and eosin. Magnification, 3440.
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et al., 1991; Williamson, 1992). The intent of this immune
response is to prevent lethal viral-induced encephalitis
(Kyuwa and Stohlman, 1990). However, these effectors
are unable to provide a sterilizing immunity within the
CNS, resulting in persistent viral antigen and RNA (Perl-
man and Ries, 1987; Adami et al., 1995), associated with
ongoing primary demyelination (Weiner, 1973). Thus, it
appears that the anti-viral effector mechanisms within
the CNS are suppressed prior to the complete elimina-
tion of virus. Consistent with these findings, the confined
space of the cranial cavity combined with the inability of
neurons to regenerate necessitates tightly controlled im-
mune responses within the CNS. In many viral infections,
functionally polarized responses as measured by anti-
viral antibody response or Th1-type cytokines are impor-
tant for viral clearance during acute infection (Kurilla et
al., 1993; Finke et al., 1995; Moran et al., 1996; Willenborg
et al., 1996). Analysis of cytokine mRNA induction during
JHMV-induced encephalitis showed that IL-10 mRNA ac-
cumulates with kinetics corresponding to the accumula-
tion of IFN-g mRNA. By contrast, the magnitude of the
IL-4 mRNA accumulation in the CNS was dramatically
less than either IL-10 or IFN-g during both lethal and
sublethal JHMV infections. These data were interpreted
to suggest that few Th-2-type T cells infiltrate the CNS
during JHMV infection (Parra et al., 1997). This interpre-
tation is consistent with both the data in this report
demonstrating no alterations in the pathogenesis in IL-4
2/2 mice and recent analysis of JHMV pathogenesis in
mice deficient in IFN-g, in which an increase in IL-4
mRNA was found in the peripheral organs, but not the
CNS (unpublished data). Together, these data suggest
that the increased IL-10 mRNA occurs predominantly in
CNS resident cells, in contrast to the active recruitment
of Th2-type T cells into the inflamed CNS. In support of
this view, it had been shown recently that normal micro-
glia/macrophages express IL-10, and in response to Toxo-
plasma infection, these cells had increased expression
of IL-10 (Schluter et al., 1997). In our model, preliminary
immunostaining of JHMV-infected C57BL/6 brain sec-
tions also showed positive expression in cells morpho-
logically identified as perivascular mononuclear cells
and parenchymal microglia (data not shown).
IL-10 is associated with both the prevention of EAE
(Rott et al., 1994) and with the remission phase of EAE
(Kennedy et al., 1992; Issazadeh et al., 1996) which fol-
lows an active attack of CNS cells by self-reactive Th1-
type T cells. The present study examined the proposition
that IL-10, predominantly secreted within the local CNS
environment, might contribute to limiting immune effec-
tors prior to complete clearance of infectious virus. Con-
sistent with this notion, CNS infection with JHMV re-
sulted in increased morbidity and mortality in IL-10 2/2
mice. However, comparisons with the pathogenesis in
syngeneic control and IL-4 2/2 mice showed that the
increased morbidity and mortality was not directly attrib-
utable to a large increase in inflammation, a delay in viral
clearance, or altered cellular tropism. These data agree
with the observed increased mortality of IL-10 2/2 mice
infected with either Toxoplasma gondii (Gazzinelli et al.,
1996) or Trypanosoma cruzi (Hunter et al., 1997), neither
of which are associated with increased parasite load.
Similarly, histopathological changes in disease models
examining the effects of IL-10 deficiency have been vari-
able. Infection of the IL-10-deficient mice with Listeria
monocytogenes or T. cruzi results in reduced tissue de-
struction, even in the presence of strong Th1-type re-
sponses (Dai et al., 1997; Hunter et al., 1997). By contrast,
in both contact hypersensitivity (Berg et al., 1995) and
systemic T. gondii infections (Gazzinelli et al., 1996), the
absence of IL-10 results in severe tissue necrosis. The
data presented in this report indicate that neither IL-10
nor IL-4 appears to be required for the suppression of
JHMV-induced CNS inflammation. These results contrast
with the proposed anti-inflammatory roles of IL-10 and
IL-4 during autoimmune-mediated CNS inflammation
(Rott et al., 1994; Kennedy et al., 1992; Racke et al., 1995;
Issazadeh et al., 1996; Shaw et al., 1997) and suggest
that these effects may reflect influences on the regula-
tion of autoimmune effector cells. These results further
suggest that other mechanisms of immune regulation
may have greater roles in suppressing inflammation in
the CNS. Growth factor deprivation has been suggested
as a potential mechanism of immune suppression within
FIG. 5. Expression of TNF-a , IFN-g, iNOS, and TGF-b mRNA in the
spinal cord of IL-10 2/2 and control mice at day 9 p.i. Semiquantitative
RT–PCR analyses were performed as described under Materials and
Methods. For each cytokine analysis, samples with the highest mRNA
expression were designated as 100% maximum response and the
remaining data were expressed as a percentage of the maximum. Data
shown are the mean of three mice 6 1 standard deviation.
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the CNS during viral-induced encephalitis (Welsh et al.,
1995). In addition, TGF-b, another potent downregulator
of inflammation, has also been suggested to function in
the CNS (Biron, 1994; Navikas and Link, 1996). Although,
the role of TGF-b in JHMV pathogenesis remains unclear,
IL-10 2/2 mice express amounts of TGF-b mRNA ap-
proximately equal to that of the control group, suggesting
a potential downregulatory role for TGF-b in JHMV CNS
infection.
Increased mortality in IL-10 2/2 mice correlated with
only a modest increase in CNS inflammation and a mod-
erate increase in the expression of inflammatory cyto-
kines. TNF-a selectively damages myelin, is cytotoxic to
oligodendrocytes (Selmaj and Raine, 1988), and is asso-
ciated with edema due to alterations in blood–brain bar-
rier permeability (Mustafa et al., 1989). However, during
JHMV infection, TNF-a depletion does not alter the mor-
bidity, mortality, extent of encephalitis, or demyelination
(Stohlman et al., 1995b). In addition to its direct cyto-
pathic effects, both TNF-a and IFN-g are potent inducers
of NO production, which has been correlated with the
severity of neuropathology in various viral infections in
the CNS (Campbell et al., 1994; Hooper et al., 1995;
Tucker et al., 1996). As with TNF-a, although the detec-
tion of elevated IFN-g and iNOS messages (Grzybicki et
al., 1997; Parra et al., 1997) might suggest that NO could
contribute to the increased morbidity and mortality, re-
cent data have demonstrated that JHMV replication and
JHMV-induced pathology are not altered in mice treated
with iNOS inhibitor (Lane et al., 1997). These data sug-
gest that TNF-a and iNOS by themselves may not directly
contribute to the pathogenesis of JHMV-induced enceph-
alomyelitis; however, it still remains possible that they
could contribute concurrently to the disease process.
Results from this report suggest that IL-10 may suppress
the expression of these inflammatory cytokines in the
CNS. This lack of suppression may be the factor explain-
ing the decreased survival of IL-10 2/2 mice at the
critical time point where even normal mice succumb to
JHMV infection. These data support a role for IL-10 in
balancing the preservation of CNS functions with viral
elimination during JHMV infection.
The observations on the lack of an important role for
TNF-a (Stohlman et al., 1995b), iNOS (Lane et al., 1997),
and IL-4 (Parra et al., 1997) during viral-induced enceph-
alomyelitis, compared to their effects on autoimmune-
mediated CNS inflammation (Selmaj and Raine, 1988;
Ruddle et al., 1990; Navikas and Link, 1996), suggest that
these two processes are regulated via independent
mechanisms. In support of this notion, the differential
regulation of two Th1-mediated inflammatory responses,
contact sensitivity (Berg et al., 1995) and delayed-type
hypersensitivity (Powrie et al., 1993), by IL-10 suggests
that viral-induced encephalomyelitis is more similar to
the mechanisms associated with delayed-type hypersen-
sitivity, while EAE is more similar to the mechanisms
regulating contact sensitivity.
MATERIALS AND METHODS
Experimental animals
Seven- to eight-week-old male (H-2b) IL-10 2/2 and
IL-4 2/2 mice were kindly provided by Dr. R. Coffman
(DNAX Research Institute, Palo Alto, CA). The homozy-
gosity of the deletions was confirmed by PCR genotyp-
ing. Age- and sex-matched C57BL/6 mice were pur-
chased from the Jackson Laboratories (Bar Harbor, ME).
All mice were seronegative for MHV antibody and were
maintained under specific pathogen-free conditions.
Virus and titer determination
Mice were infected by intracerebral (ic) inoculation
with 25 PFU of the 2.2v-1 monoclonal antibody (mAb)
escape variant of JHMV contained in 32 ml of phosphate-
buffered saline (PBS). The 2.2v-1 virus, kindly supplied by
Dr. J. Fleming (University of Wisconsin), produces a sub-
lethal infection with severe demyelinating disease (Flem-
ing et al., 1986) and was tested for reversion prior to use.
JHMV replication in the CNS was determined by plaque
assay on monolayers of DBT cells as previously de-
scribed (Stohlman et al., 1986). Briefly, one half of the
brains was homogenized in 2.0 ml of Dulbecco’s PBS (pH
7.4), using Ten Broeck tissue homogenizers. The other
half was processed for histology (see below). Following
centrifugation at 200 g for 7 min at 4°, supernatants were
either assayed immediately or frozen at 270°C. Data
presented are the average of triplicate determinations for
groups of four or more mice.
Clinical scores
Clinical disease was graded as previously described
(Fleming et al., 1988): 0, healthy; 1, ruffled fur and
hunched backs; 2, slow mobility and inability to return to
upright position when turned on its back; 3, paralysis and
wasting; 4, moribund and death. Average clinical scores
for at least four mice per group are reported.
Cytokine mRNA expression
RNA was prepared from half spinal cords by homog-
enization in guanidine isothiocyanate and isolated by
centrifugation through 5.4 M cesium chloride at 100,000
g for 18 h as previously described (Cua et al., 1995; Parra
et al., 1997). The cDNA were prepared using avian my-
eloblastosis reverse transcriptase (Promega, Madison,
WI) and oligo(dT) primers (Promega) for 60 min at 42°C.
Expression of cytokine mRNA was determined by semi-
quantitative PCR analysis, following procedures de-
scribed previously (Cua et al., 1995; Parra et al., 1997).
PCR was performed using AmpliTaq DNA polymerase
(Perkin–Elmer, Branchburg, NJ) and specific cytokine
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primers for TNF-a, IFN-g, and iNOS as previously de-
scribed (Parra et al., 1997). For quantification, PCR prod-
ucts were diluted in denaturing solution (0.4 N NaOH, 25
mM EDTA), neutralized with Tris–HCL (1.0 M; pH 8.0), and
transferred to 0.45-mm Nytran membranes (Schleicher &
Schuell, Keene, NH) using a Minifold I dot blot apparatus.
Membranes were hybridized (60°C, overnight) with
[32P]ATP-labeled internal oligonucleotide probes. Mem-
branes were washed (three times; 23 SSC, 0.1% SDS;
room temperature), exposed to Storage phosphor
Screens (Molecular Dynamics, Sunnyvale, CA), and
scanned using phosphorimaging scanner (Molecular Dy-
namics). To adjust for differences in the amount of cDNA,
cytokine cDNA levels were normalized to the house-
keeping enzyme hypoxanthine phosphoriboxyltrans-
ferase (HPRT) as previously described (Cua et al., 1995;
Parra et al., 1997). For each cytokine, the highest mean
specific activity was designated as 100% maximal re-
sponse. The remainder of the samples were expressed
as a percentage of the highest value. Data shown are
mean value of three mice 6 1 standard deviation.
In vivo depletion of cytokines
Groups of C57BL/6 mice were treated intraperitoneally
with 1 mg of purified anti-IL-4 (11B11), or anti-IL-10 (JES5-
2A5), or an isotype-matched control anti-b-galactosidase
mAb (GL113) (kindly provided by Dr. R. Coffman, DNAX
Research Institute, Palo Alto, CA) 2 days prior to and 2
days postinfection (p.i.). We had shown previously that
rat mAb of the same isotype when similarly administered
was able to cross the blood–brain barrier during JHMV
infection (Stohlman et al., 1995b). Purified mAbs were
prepared from serum-free culture supernatants and con-
tained less than 3 EU of endotoxin/mg.
Histology
One half of the brains and the spinal cords from three
to four mice per group were fixed for 3 h in Clark’s
solution (75% ethanol, 25% glacial acetic acid) and em-
bedded in paraffin. Distribution of JHMV antigen was
examined by immunoperoxidase staining (Vectastain-
ABC kit; Vector Laboratory, Burlingame, CA) using the
anti-JHMV mAb J.3.3 specific for the carboxy terminus of
the N protein as primary antibody (Fleming et al., 1983)
and horse anti-mouse monoclonal antibody as the sec-
ondary antibody (Vector Laboratory, CA) and then coun-
terstained with hematoxylin and eosin. Multiple serial-
step paraffin sections of the spinal cord were stained
with luxol fast blue. The number of demyelinating
plaques was counted to compare the extent and distri-
bution of demyelinating lesions. CD41 and CD81 T cells
were identified by immunostaining acetone-fixed frozen
sections using anti-CD4 (H129.19, Pharmingen, San Di-
ego, CA) and anti-CD8 (53-6.7, Pharmingen) antibodies at
1:200 dilution. Primary antibodies were then detected
with biotin-conjugated rabbit anti-rat antibody preab-
sorbed with mouse serum (Vector Laboratory) and Vec-
stain-ABC kit.
Statistics
For comparison of clinical scores and mortality, the
Kruskal–Wallis and the Mantel–Cox tests were per-
formed, respectively. Differences in virus titers and the
numbers of demyelinating plaques were compared using
the Student’s t test.
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